海利品牌怎么样 申请店铺

我要投票 海利在兽药行业中的票数:214 更新时间:2025-04-28
海利是哪个国家的品牌?「海利」是 上海海利生物技术股份有限公司 旗下著名品牌。该品牌发源于上海,由创始人张海明在1981期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力海利品牌出海!通过在本页面挂载海利品牌的产品链接和联系方式,可以提高海利产品曝光!跨境电商爆单神器,目前只要100元/年哦~

海利怎么样

上海海利生物技术股份有限公司(以下简称“海利生物”)位于上海奉贤经济开发区金海路6720号,其前身为上海松江生物药品厂,是农业部在上海批准生产兽用生物制品的定点企业及农业部在上海设立的动物重大疫情防治生产基地。作为一家专业的动物保健品公司,海利生物能够为预防动物疾病、改善动物福利和提高养殖业主的生产效益提供综合解决方案。海利生物的产品和服务涵盖了家畜、家禽以及宠物等多个领域。

海利生物是上海市高新技术企业、上海市农业产业化重点龙头企业、上海兽用生物制品工程技术研究中心、上海市科技小巨人(培育)企业;海利生物商标被认定为上海市著名商标,公司的疫苗产品荣获“上海名牌”称号;海利生物为上海农林职业技术学院(生物技术专业)的实习培训基地。

海利生物拥有11条GMP生产线,自主生产家畜、家禽两大系列共40多个产品。多年来,海利生物坚持科技创新之路,以市场为导向、以产品为依托,销售网络遍布全国,销售业绩成倍增长。海利生物现有员工近450名,其中专业技术人员占50%以上。海利生物坚持以人为本的人才战略,已建立起经营高效的管理团队、技术精湛的研发团队以及技能娴熟的员工团队。

在企业快速发展中,海利生物高度重视产、学、研相结合的产品战略,以市场为导向,几年来先后与国内行业领先的中国科学院、中国农科院哈尔滨兽医研究所、南京农业大学、河南农业大学等科研机构合作,共同开发具有国内外先进水平的兽用生物疫苗。特别是拥有了猪繁殖与呼吸综合征活疫苗(即蓝耳病活疫苗)、猪圆环病毒2型灭活疫苗(LG株)、猪传染性胃肠炎和流行性腹泻二联灭活疫苗、猪链球菌二联灭活疫苗、鸡新城疫/传染性支气管炎/减蛋综合征/禽流感(H9N2)四联灭活疫苗等国家一、二类新药的知识产权,其中多个新产品的研发及产业化项目获得了上海市科委、上海市经委的科技创新项目立项支持。海利生物的猪繁殖与呼吸综合征活疫苗(即蓝耳病活疫苗)、猪传染性胃肠炎和流行性腹泻二联灭活疫苗、猪圆环病毒2型灭活疫苗、猪链球菌灭活疫苗、高致病性猪繁殖与呼吸综合征活疫苗已先后被认定为上海市科委高新技术成果转化项目,猪链球菌二联灭活疫苗荣获上海市科技进步二等奖。尤其从2007年开始,在全国范围内爆发的猪蓝耳病疫情防治工作中,海利生物承担了农业部定点生产高致病性猪蓝耳病疫苗的重要任务,为广大养殖户提供优质、可靠的疫苗,及时有效地防控了疫情的蔓延。

海利生物致力于为预防畜禽疾病、改善畜禽健康和提高养殖业主的生产效益服务,并能够提供综合解决方案和权威的兽医专家服务系统。为满足市场需求,海利生物一如既往地坚持自主创新及高新技术产业化发展的战略重点,力争跻身国内兽用生物疫苗行业前列。



Shanghai Haili Biotechnology Co., Ltd. (hereinafter referred to as "Haili biology") is located at No. 6720, Jinhai Road, Fengxian Economic Development Zone, Shanghai. Its predecessor is Shanghai Songjiang biological medicine factory. It is a designated enterprise approved by the Ministry of agriculture to produce biological products for animal use in Shanghai and a production base for animal major epidemic prevention and control established by the Ministry of agriculture in Shanghai. As a professional animal health products company, Haili bio can provide comprehensive solutions for preventing animal diseases, improving animal welfare and improving the production efficiency of breeding owners. Haili's products and services cover livestock, poultry and pets. Haili biology is a high-tech enterprise in Shanghai, a key leading enterprise of agricultural industrialization in Shanghai, a research center of animal biological products engineering technology in Shanghai, and a small giant (cultivation) enterprise of science and technology in Shanghai. Haili biology trademark is recognized as a famous trademark in Shanghai, The company's vaccine products won the title of "Shanghai famous brand"; Haili biology is the practice training base of Shanghai Agricultural and Forestry Vocational Technical College (Biotechnology Major). Haili biological has 11 GMP production lines, and independently produces more than 40 products in two series of livestock and poultry. Over the years, Haili biology adheres to the road of scientific and technological innovation, is market-oriented and product-based, with its sales network all over the country, and its sales performance has multiplied. Haili biology has nearly 450 employees, of which more than 50% are professional technicians. Haili biology adheres to the human-oriented talent strategy and has established an efficient management team, a skilled R & D team and a skilled staff team. In the rapid development of the enterprise, Haili biology attaches great importance to the product strategy of combining production, learning and research, and is market-oriented. In recent years, Haili biology has cooperated with Chinese Academy of Sciences, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Nanjing Agricultural University, Henan Agricultural University and other scientific research institutions to jointly develop animal biological vaccines with advanced level at home and abroad. In particular, it has the knowledge production of the first and second class new drugs in China, such as the live vaccine of porcine reproductive and respiratory syndrome (i.e. the live vaccine of blue ear disease), the inactivated vaccine of porcine circovirus type 2 (LG strain), the inactivated vaccine of swine infectious gastroenteritis and epidemic diarrhea, the inactivated vaccine of Streptococcus suis, the inactivated vaccine of Newcastle disease / infectious bronchitis / egg drop syndrome / avian influenza (H9N2), etc Among them, R & D and industrialization projects of many new products have been supported by science and technology innovation projects of Shanghai Municipal Commission of science and technology and Shanghai Economic Commission. Haili bio's live vaccine for porcine reproductive and respiratory syndrome (i.e. live vaccine for blue ear disease), bivalent inactivated vaccine for transmissible gastroenteritis and epidemic diarrhea, bivalent inactivated vaccine for porcine circovirus type 2, Streptococcus suis, and highly pathogenic live vaccine for porcine reproductive and respiratory syndrome have been successively recognized as the high-tech achievement transformation project of Shanghai Science and Technology Commission, bivalent inactivated vaccine for Streptococcus suis Won the second prize of Shanghai Science and technology progress award. Especially since 2007, in the prevention and control of the outbreak of blue ear disease nationwide, Haili biology has undertaken the important task of producing highly pathogenic blue ear disease vaccine designated by the Ministry of agriculture, providing high-quality and reliable vaccine for the majority of farmers, and preventing and controlling the spread of the disease in time and effectively. Haili biology is committed to the prevention of livestock and poultry diseases, improve the health of livestock and poultry and improve the production efficiency of breeding owners, and can provide comprehensive solutions and authoritative veterinary expert service system. In order to meet the market demand, Haili biology, as always, adheres to the strategic focus of independent innovation and the development of high-tech industrialization, and strives to be in the forefront of domestic veterinary biological vaccine industry.

本文链接: https://brand.waitui.com/5c9756dfe.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

惠誉博华:商业银行扩表节奏趋缓

36氪获悉,近日惠誉博华商业银行2024年度业绩点评。报告显示,2024年商业银行总资产同比增速回落至4.8%,结束此前连续三年的双位数扩张周期。从银行机构类型看呈现显著分化态势:城商行以8.9%的资产增速领跑,农商行以6.0%的增速紧随其后,国有大行与股份制银行分别录得3.9%和2.7%的增速。这种梯度差异映射出不同类别银行面临的经营环境——头部城商行凭借区域经济韧性维持相对活跃的资产扩张,而股份制银行负债端受制于存款成本刚性约束难以匹配国有大行资金优势,资产端受风险偏好与定价能力限制难以深度渗透区域下沉市场,导致信贷资源配置效率持续承压,近三年资产增速中枢较2019至2021年下降逾6个百分点,信贷市场正从增量竞争向存量优化转换。

9分钟前

EHL酒店管理商学院将举办2025 年首届开放创新峰会

36氪获悉,EHL酒店管理商学院近日宣布,首届 EHL开放创新峰会将于5月20-21日在EHL瑞士洛桑校区举行。据悉本届峰会将围绕食品的未来、再生经济、奢品新义三个主题,打造切实可行的解决方案。EHL创新中心首席执行官Andrea Monti指出:“在这样一个充满活力与变革的时代,酒店及泛服务业对创新的需求比以往任何时候都更为迫切。”

9分钟前

字节启动Top Seed大模型顶尖人才计划2026届校招

36氪获悉,4月27日,字节跳动Seed正式启动2026届Top Seed大模型顶尖人才校招计划。据了解,此前3月Top Seed开放了研究型实习生招聘,今日起正式启动2026届校招,计划招募约30位顶尖应届博士。本届Top Seed研究课题包括大语言模型、机器学习算法和系统、多模态生成、多模态理解、语音等方向,基本覆盖大模型研究各个领域。值得一提的是,本届Top Seed强调不限专业背景,更关注研究潜力,希望寻找具有极强技术信仰与热情、具备出色研究能力、富有好奇心和驱动力的年轻研究者。

9分钟前

硅基智能1000万美元购入DUIX.com域名

近日,AI数字人科技公司硅基智能以1000万美元收购稀缺四字母.com域名DUIX.com,并同步上线同名数字人实时交互平台。据介绍,DUIX,全称Dialogue User Interface System,定位为新一代数字人智能交互基础设施,提供API接入、SDK开发包、免费实时体验入口及多场景应用案例。该平台支持数字人多模态交互,覆盖情感陪伴、客服、教育、医疗、游戏等应用场景,帮助开发者快速搭建实时交互式体验。

9分钟前

万兴科技董事长吴太兵: 以MCP类技术为基础的AI Agent,将重构软件生态

36氪获悉,万兴科技董事长吴太兵近期出席活动时表示,AI Agent是一个很大的机会,以MCP、A2A类技术为基础的AI Agent,将重构软件生态。从文本界面(DOS)到图形界面(GUI),到指令交互界面(CUI),再到如今的MCP类技术为基础的AI Agent,其转变将为整个软件行业带来新的变革。公司过去在音视频及AI领域积累了丰富的经验和能力,对MCP类技术方向持积极态度,也相信随着MCP生态的成熟和扩展,将为AI产业、为AIGC创意软件带来更多的创新和增长机会。公开资料显示,万兴科技全年AI服务器累计调用超5亿次,AI素材用户共导出超1400万次,同比提升超700%。

9分钟前

本页详细列出关于海利的品牌信息,含品牌所属公司介绍,海利所处行业的品牌地位及优势。
咨询